BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 50 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $613,257 | -26.0% | 42,558 | -15.7% | 0.00% | 0.0% |
| Q2 2023 | $829,232 | -8.9% | 50,501 | -7.3% | 0.00% | -50.0% |
| Q1 2023 | $910,617 | +3.3% | 54,495 | -4.6% | 0.00% | 0.0% |
| Q4 2022 | $881,655 | -1.6% | 57,139 | -4.8% | 0.00% | 0.0% |
| Q3 2022 | $896,000 | -9.9% | 60,016 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $995,000 | -52.8% | 60,571 | -42.4% | 0.00% | -33.3% |
| Q1 2022 | $2,110,000 | -27.6% | 105,185 | -8.5% | 0.00% | -25.0% |
| Q4 2021 | $2,915,000 | -3.5% | 114,953 | +2.6% | 0.00% | -20.0% |
| Q3 2021 | $3,022,000 | -5.8% | 111,991 | +0.9% | 0.01% | 0.0% |
| Q2 2021 | $3,209,000 | +2.3% | 110,957 | -7.0% | 0.01% | 0.0% |
| Q1 2021 | $3,137,000 | -3.2% | 119,281 | +5.5% | 0.01% | -16.7% |
| Q4 2020 | $3,240,000 | +26.7% | 113,072 | +5.5% | 0.01% | 0.0% |
| Q3 2020 | $2,557,000 | +20.7% | 107,195 | +5.8% | 0.01% | +20.0% |
| Q2 2020 | $2,119,000 | +477.4% | 101,336 | +394.8% | 0.01% | +400.0% |
| Q1 2020 | $367,000 | – | 20,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |